A cell-penetrant lactam-stapled peptide for targeting eIF4E protein-protein interactions

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Therapeutics

Background:

• Eukaryotic translation initiation factor 4E (eIF4E) is crucial for cap-dependent translation initiation.
• Accelerated translation by eIF4E is observed in tumorigenesis, making it a key cancer target.
• eIF4E interacts with 4E-BP1 (inhibitor) and eIF4G (stimulator) via helical protein-protein interactions (PPIs).

Purpose of the Study:

• To develop novel therapeutic strategies targeting eIF4E.
• To design and characterize helical mimetics of eIF4E binding partners, specifically 4E-BP1.
• To create a cell-penetrant peptide capable of inhibiting eIF4E PPIs.

Main Methods:

• Development of lactam stapled peptides.
• Characterization of peptide properties, including cell penetration.
• Assessment of peptide efficacy in targeting eIF4E interactions.

Main Results:

• Successful development of a cell-penetrant lactam stapled peptide.
• The peptide is designed to mimic the helical structure of 4E-BP1.
• Demonstrated potential for targeting cellular eIF4E.

Conclusions:

• Helical mimetics, like stapled peptides, are viable strategies for inhibiting eIF4E PPIs.
• The developed peptide represents a promising new therapeutic agent for cancer.
• Further research is warranted to explore the clinical applications of this eIF4E-targeting peptide.